Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
We examined the interplay between the insulin/IGF-1- and beta-catenin-regulated pathways, both of which are suspected to play a role in hepatocarcinogenesis. Insulin and IGF-1 stimulated the transcription of a Lef/Tcf-dependent luciferase reporter gene by 3-4-fold in HepG2 cells. This stimulation was mediated through the activation of phosphatidylinositol 3-kinase (PI 3-K)/Akt and the inhibition of glycogen synthase kinase-3beta (GSK-3beta) since the effects of insulin and IGF-1 were inhibited by dominant-negative mutants of PI 3-K or Akt and an uninhibitable GSK-3beta. Together with inhibiting GSK-3beta, insulin and IGF-1 increased the cytoplasmic levels of beta-catenin. The PI 3-K/Akt/GSK-3beta pathway was not the sole to mediate insulin and IGF-1 stimulation of Lef/Tcf-dependent transcription. The Ras signalling pathway was also required as (i) the stimulatory effects of insulin and IGF-1 were inhibited by dominant-negative Ras or the MEK1 inhibitor PD98059 and (ii) activated Ha-Ras or constitutively active MEK1 synergized with catalytically inactive GSK-3beta to stimulate Lef/Tcf-dependent transcription. This study provides the first evidence that insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades bifurcating downstream of PI 3-K and involving GSK-3beta inhibition and Ras activation. These findings demonstrate for the first time the ability of insulin and IGF-1 to activate the beta-catenin pathway in hepatoma cells and thereby provide new insights into the role of these factors in hepatocarcinogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cross-talk between the Wnt and insulin signaling pathways has been demonstrated in different disorders such as diabetes and cancer49-53.”
From Altered proliferation and networks in neural cells derived from idiopathic autistic individuals (2017) · cites this paper as [52]
Citations
Cites
Michalopoulos, G. K., & DeFrances, M. C. (1997) · Science · doi:10.1126/science.276.5309.60 · Cited by 2,828
β-catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,529 · cited 2×
“Results are representative of three independent experiments Oncogene zation in Wnt/Wingless signalling (Aberle et al., 1997), we next wished to examine whether insulin- and IGF-1mediated GSK-3b inhibition a ected the level of bcatenin found in the cytoplasm of HepG2 cells.”
BackgroundA molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301 · cited 1×
“Consistent with this, treatment with lithium chloride (LiCl), a pharmacological agent well-known for its inhibitory e ect on GSK-3b activity (Klein and Melton, 1996; Stambolic et al., 1996), increased reporter activity (Figure 3b).”
BackgroundMECHANISMS OF WNT SIGNALING IN DEVELOPMENT
Wodarz, A., & Nusse, R. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.59 · Cited by 2,017 · cited 1×
“This pathway plays a critical role in development, proliferation and di erentiation (Wodarz and Nusse, 1998).”
BackgroundBinding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly
Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S., & Polakis, P. (1996) · Science · doi:10.1126/science.272.5264.1023 · Cited by 1,422 · cited 1×
“…molecular mass complex including adenomatous polyposis coli (APC) (Su et al., 1993; Rubinfeld et al., 1993), glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996), and axin (Hart et al., 1998; Behrens et al., 1998). bcatenin is phosphorylated by GSK-3b (Ikeda et al., 1998) and targeted…”
BackgroundLithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321 · cited 1×
“Consistent with this, treatment with lithium chloride (LiCl), a pharmacological agent well-known for its inhibitory e ect on GSK-3b activity (Klein and Melton, 1996; Stambolic et al., 1996), increased reporter activity (Figure 3b).”
BackgroundFunctional Interaction of an Axin Homolog, Conductin, with β-Catenin, APC, and GSK3β
Behrens, J., Jerchow, B.-A., Würtele, M., Grimm, J., Asbrand, C., Wirtz, R., Kühl, M., Wedlich, D., & Birchmeier, W. (1998) · Science · doi:10.1126/science.280.5363.596 · Cited by 1,260 · cited 1×
“…coli (APC) (Su et al., 1993; Rubinfeld et al., 1993), glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996), and axin (Hart et al., 1998; Behrens et al., 1998). bcatenin is phosphorylated by GSK-3b (Ikeda et al., 1998) and targeted for degradation by the ubiquitin/ proteasome system…”
BackgroundIkeda, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.5.1371 · Cited by 1,246 · cited 1×
“…et al., 1993; Rubinfeld et al., 1993), glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996), and axin (Hart et al., 1998; Behrens et al., 1998). bcatenin is phosphorylated by GSK-3b (Ikeda et al., 1998) and targeted for degradation by the ubiquitin/ proteasome system (Aberle et al., 1997).”
BackgroundAssociation of the APC Gene Product with β-Catenin
Rubinfeld, B., Souza, B., Albert, I., Müller, O., Chamberlain, S. H., Masiarz, F. R., Munemitsu, S., & Polakis, P. (1993) · Science · doi:10.1126/science.8259518 · Cited by 1,223 · cited 1×
“…adherens junctions and any free b-catenin interacts with a high molecular mass complex including adenomatous polyposis coli (APC) (Su et al., 1993; Rubinfeld et al., 1993), glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996), and axin (Hart et al., 1998; Behrens et al., 1998). bcatenin…”
BackgroundAssociation of the APC Tumor Suppressor Protein with Catenins
Su, L.-K., Vogelstein, B., & Kinzler, K. W. (1993) · Science · doi:10.1126/science.8259519 · Cited by 1,188 · cited 2×
“…mainly at adherens junctions and any free b-catenin interacts with a high molecular mass complex including adenomatous polyposis coli (APC) (Su et al., 1993; Rubinfeld et al., 1993), glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996), and axin (Hart et al., 1998; Behrens et al.,…”
BackgroundSomatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
Coste, A. D. L., Romagnolo, B., Billuart, P., Renard, C.-A., Buendia, M.-A., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C., Kahn, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8847 · Cited by 1,121 · cited 5×
“…show that human liver cancer is associated with a constitutive activation of the b-catenin pathway as a result of activating and inactivating mutations in b-catenin and axin, respectively (de La Coste et al., 1998; Miyoshi et al., 1988; Nhieu et al., 1999; Terris et al., 1999; Satoh et al., 2000).”
BackgroundInfluentialSelf-citationDelcommenne, M., Tan, C., Gray, V., Rue, L., Woodgett, J., & Dedhar, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11211 · Cited by 1,092 · cited 1×
“K and Akt which Oncogene is activated by insulin, was reported to stimulate Akt activity as well as Lef/Tcf-dependent transcription in rat intestinal epithelial cells (IEC-18) (Delcommenne et al., 1998; Novak et al., 1998).”
BackgroundRole of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway
Pap, M., & Cooper, G. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.19929 · Cited by 1,040 · cited 1×
“In preliminary experiments, we observed that overexpression of a catalytically inactive GSK-3b (R85GSK-3b) which acts as a dominantnegative mutant of endogenous GSK-3b (Pap and Cooper, 1998) stimulated pTOPFLASH luciferase activity (Figure 3a).”
BackgroundSatoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N., Nishiwaki, T., Kawasoe, T., Ishiguro, H., Fujita, M., Tokino, T., et al. (2000) · Nature Genetics · doi:10.1038/73448 · Cited by 960 · cited 13×
“However the molecular mechanisms underlying HCC development are still poorly understood.”
BackgroundInfluentialPhosphoinositide 3-kinase: the key switch mechanism in insulin signalling
SHEPHERD, P. R., WITHERS, D. J., & SIDDLE, K. (1998) · Biochemical Journal · doi:10.1042/bj3330471 · Cited by 953 · cited 2×
“K which mediates some of the metabolic, proliferative and antiapoptotic functions of insulin and IGF-1 (Shepherd et al., 1998).”
BackgroundHart, M. J., de los Santos, R., Albert, I. N., Rubinfeld, B., & Polakis, P. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70226-x · Cited by 836 · cited 1×
“…adenomatous polyposis coli (APC) (Su et al., 1993; Rubinfeld et al., 1993), glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996), and axin (Hart et al., 1998; Behrens et al., 1998). bcatenin is phosphorylated by GSK-3b (Ikeda et al., 1998) and targeted for degradation by the ubiquitin/…”
BackgroundThe oncogenic activation of β-catenin
Polakis, P. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80003-3 · Cited by 653 · cited 2×
“Furthermore, inactivating mutations of axin, a negative regulator of the b-catenin signalling pathway, were reported in HCC (Satoh et al., 2000). b-catenin is a multifunctional protein (Polakis, 1999; Barker et al., 2000).”
BackgroundRegulation of gene expression by insulin
O'Brien, R. M., & Granner, D. K. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.4.1109 · Cited by 540 · cited 1×
“Since this pathway mediates insulin and IGF-1 regulation of gene expression (O'Brien and Granner, 1996), it would be of interest to examine whether it contributes to the stimulation of Lef/Tcf-dependent transcription by increasing the expression of Lef/Tcf factors.”
BackgroundThe IRS-signalling system: A network of docking proteins that mediate insulin action
White, M. F. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006806722619 · Cited by 534
Cross, D. A. E., Alessi, D. R., Vandenheede, J. R., McDowell, H. E., Hundal, H. S., & Cohen, P. (1994) · Biochemical Journal · doi:10.1042/bj3030021 · Cited by 478
Cell adhesion and the integrin-linked kinase regulate the LEF-1 and β-catenin signaling pathways
Novak, A., Hsu, S.-C., Leung-Hagesteijn, C., Radeva, G., Papkoff, J., Montesano, R., Roskelley, C., Grosschedl, R., & Dedhar, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4374 · Cited by 434 · cited 3×
“While the overexpression of activated Ha-Ras strongly stimulated Lef/Tcf-dependent transcription in HepG2 cells, it was reported to have no major e ect on this process in rat intestinal epithelial cells (Novak et al., 1998) and keratinocytes (Espada et al., 1999).”
BackgroundCook, D., Fry, M. J., Hughes, K., Sumathipala, R., Woodgett, J. R., & Dale, T. C. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00830.x · Cited by 388 · cited 1×
“K and Akt are not cytoplasmic mediators in the Wnt/Wingless signalling cascades (Cook et al., 1996; Torres et al., 1999; Yuan et al., 1999).”
BackgroundEssential Role for Protein Kinase B (PKB) in Insulin-induced Glycogen Synthase Kinase 3 Inactivation
van Weeren, P. C., de Bruyn, K. M. T., de Vries-Smits, A. M. M., van Lint, J., & Burgering, B. M. T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13150 · Cited by 365 · cited 1×
“K and Akt (van Weeren et al., 1998).”
Nhieu, J. T. V., Renard, C. A., Wei, Y., Cherqui, D., Zafrani, E. S., & Buendia, M. A. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65168-1 · Cited by 295 · cited 2×
“Indeed, activating mutations of b-catenin are present in HCC (de La Coste et al., 1998; Miyoshi et al., 1998; Nhieu et al., 1999; Terris et al., 1999) as well as in some hepatoma cell lines (de La Coste et al., 1998).”
BackgroundThe Yin-Yang of TCF/β-Catenin Signaling
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60783-6 · Cited by 291 · cited 1×
“Furthermore, inactivating mutations of axin, a negative regulator of the b-catenin signalling pathway, were reported in HCC (Satoh et al., 2000). b-catenin is a multifunctional protein (Polakis, 1999; Barker et al., 2000).”
BackgroundThe Role of Glycogen Synthase Kinase 3β in Insulin-stimulated Glucose Metabolism
Summers, S. A., Kao, A. W., Kohn, A. D., Backus, G. S., Roth, R. A., Pessin, J. E., & Birnbaum, M. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17934 · Cited by 212 · cited 1×
“This plasmid encodes a mutant GSK-3b in which the serine 9 phosphorylation site is mutated to alanine (Summers et al., 1999).”
BackgroundCariani, E., Lasserre, C., Seurin, D., Hamelin, B., Kemeny, F., Franco, D., Czech, M., Ullrich, A., & Bréchot, C. (1988) · PubMed · Cited by 193
Chen, R.-H., Su, Y.-H., Chuang, R. L., & Chang, T.-Y. (1998) · Oncogene · doi:10.1038/sj.onc.1202111 · Cited by 186 · cited 1×
“Insulin and insulin-like growth factors (IGFs) have been also reported to act as potent survival factors for hepatoma cells (Tanaka and Wands, 1996; Chen et al., 1998; Buchmann et al., 1999).”
BackgroundMutant Presenilin-1 Induces Apoptosis and Downregulates Akt/PKB
Weihl, C. C., Ghadge, G. D., Kennedy, S. G., Hay, N., Miller, R. J., & Roos, R. P. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-13-05360.1999 · Cited by 137 · cited 1×
“Thus, the expression of mutant presenilin-1 in rat hippocampal neurons and PC12 cells induced apoptosis through downregulation of both Akt activity and b-catenin expression (Weihl et al., 1999).”
BackgroundRole of binding proteins to IRS-1 in insulin signalling
Ogawa, W., Matozaki, T., & Kasuga, M. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006862807598 · Cited by 132
Terris, B., Pineau, P., Brégeaud, L., Valla, D. C., Belghiti, J., Tiollais, P., Degott, C., & Dejean, A. (1999) · Oncogene · doi:10.1038/sj.onc.1203051 · Cited by 131 · cited 2×
“Indeed, activating mutations of b-catenin are present in HCC (de La Coste et al., 1998; Miyoshi et al., 1998; Nhieu et al., 1999; Terris et al., 1999) as well as in some hepatoma cell lines (de La Coste et al., 1998).”
BackgroundPTEN/MMAC1 mutations in hepatocellular carcinomas
Yao, Y. J., Ping, X. L., Zhang, H., Chen, F. F., Lee, P. K., Ahsan, H., Chen, C., Lee, P., Peacocke, M., Santella, R. M., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202659 · Cited by 128 · cited 13×
“However the molecular mechanisms underlying HCC development are still poorly understood.”
BackgroundInfluentialMutation of β-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis
Devereux, T. R., Anna, C. H., Foley, J. F., White, C. M., Sills, R. C., & Barrett, J. C. (1999) · Oncogene · doi:10.1038/sj.onc.1202858 · Cited by 123 · cited 1×
“In addition, activating mutations of b-catenin were identi®ed in rodent hepatocellular neoplasms induced by diverse chemical carcinogens (Devereux et al., 1999; Ogawa et al., 1999; Tsujiuchi et al., 1999).”
BackgroundNishiyama, M., & Wands, J. R. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91640-c · Cited by 114 · cited 2×
“Therefore, they strongly suggest that the frequent upregulation of the insulin/IGF signalling pathways observed in HCC (Cariani et al., 1988, 1991; Nishiyama and Wands, 1992; Su et al., 1994; Nardone et al., 1996; Kim et al., 1996; Tanaka et al., 1997; Yao et al., 1999) contributes to hepatic…”
BackgroundBiological effects of human insulin receptor substrate-1 overexpression in hepatocytes
Tanaka, S., Mohr, L., Schmidt, E. V., Sugimachi, K., & Wands, J. R. (1997) · Hepatology · doi:10.1002/hep.510260310 · Cited by 111 · cited 4×
“K/Akt and Ras/extracellularregulated kinases (ERKs) pathways.”
BackgroundInfluentialYuan, H., Mao, J., Li, L., & Wu, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30419 · Cited by 104 · cited 2×
“In agreement with our ®ndings, GSK-3b inhibition was reported not to be su cient for mediating Lef/Tcfdependent transcription in T lymphocytes (Staal et al., 1999) and in NIH3T3 cells (Yuan et al., 1999).”
BackgroundSu, Q., Liu, Y.-F., Zhang, J.-F., Zhang, S.-X., Li, D.-F., & Yang, J.-J. (1994) · Hepatology · doi:10.1002/hep.1840200404 · Cited by 101
西山, 正. (1994) · Medical Entomology and Zoology · doi:10.11501/3096694 · Cited by 100
Role of binding proteins to IRS-1 in insulin signalling.
Ogawa, W., Matozaki, T., & Kasuga, M. (1998) · PubMed · Cited by 98
Egawa, K., Sharma, P. M., Nakashima, N., Huang, Y., Huver, E., Boss, G. R., & Olefsky, J. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.14306 · Cited by 90 · cited 1×
“K in diverse insulin-mediated biological e ects (Shepherd et al., 1998; Egawa et al., 1999), we tested the involvement of the Ras signalling pathway.”
BackgroundInsulin Activates Nuclear Factor κB in Mammalian Cells through a Raf-1-mediated Pathway
Bertrand, F., Philippe, C., Antoine, P. J., Baud, L., Groyer, A., Capeau, J., & Cherqui, G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24435 · Cited by 83 · cited 1×
“Seventeen hours posttransfection, cells were serum-deprived for 10 h and then stimulated with insulin or IGF-1 for 17 h. Cells were lysed and assayed for luciferase activity as previously described (Bertrand et al., 1995). bgalactosidase activity was assessed using the Galacto-LightTM kit (Tropix).”
MethodSelf-citationEspada, J., Pérez-Moreno, M., Braga, V. M. M., Rodriguez-Viciana, P., & Cano, A. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.967 · Cited by 81 · cited 1×
“While the overexpression of activated Ha-Ras strongly stimulated Lef/Tcf-dependent transcription in HepG2 cells, it was reported to have no major e ect on this process in rat intestinal epithelial cells (Novak et al., 1998) and keratinocytes (Espada et al., 1999).”
BackgroundStaal, F. J. T., Burgering, B. M. T., van de Wetering, M., & Clevers, H. C. (1999) · International Immunology · doi:10.1093/intimm/11.3.317 · Cited by 75
Torres, M. A., Eldar-Finkelman, H., Krebs, E. G., & Moon, R. T. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1427 · Cited by 66 · cited 1×
“K and Akt are not cytoplasmic mediators in the Wnt/Wingless signalling cascades (Cook et al., 1996; Torres et al., 1999; Yuan et al., 1999).”
BackgroundNardone, G., Romano, M., Calabrò, A., Pedone, P. V., de Sio, I., Persico, M., Budillon, G., Bruni, C. B., Riccio, A., & Zarrilli, R. (1996) · Hepatology · doi:10.1002/hep.510230602 · Cited by 62 · cited 2×
“Thus, increased expression of IGF-II (Cariani et al., 1988, 1991; Su et al., 1994; Nardone et al., 1996), IGF-1 receptor or IRS-1 (Kim et al., 1996; Nishiyama and Wands, 1992; Tanaka et al., 1997) were frequently observed.”
BackgroundOgawa, K., Yamada, Y., Kishibe, K., Ishizaki, K., & Tokusashi, Y. (1999) · PubMed · Cited by 59
Desbois-Mouthon, C. (2000) · Endocrinology · doi:10.1210/en.141.3.922 · Cited by 46
Self-citationCariani, E., Lasserre, C., Kemeny, F., Franco, D., & Bréchot, C. (1991) · Hepatology · doi:10.1002/hep.1840130406 · Cited by 40 · cited 14×
“However the molecular mechanisms underlying HCC development are still poorly understood.”
BackgroundInfluentialTsujiuchi, T., Tsutsumi, M., Sasaki, Y., Takahama, M., & Konishi, Y. (1999) · PubMed · Cited by 35
The molecular pathogenesis of hepatocellular carcinoma
Moradpour, D., & Wands, J. R. (1994) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.1994.tb00058.x · Cited by 33 · cited 12×
“However the molecular mechanisms underlying HCC development are still poorly understood.”
BackgroundInfluentialBuchmann, A., Willy, C., Buenemann, C. L., Stroh, C., Schmiechen, A., & Schwarz, M. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400475 · Cited by 32 · cited 1×
“Insulin and insulin-like growth factors (IGFs) have been also reported to act as potent survival factors for hepatoma cells (Tanaka and Wands, 1996; Chen et al., 1998; Buchmann et al., 1999).”
Background
Research works printed but not linked: 1
- Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoël MJ, Bertrand F, Caron M, Atfi A, Cherqui G and Capeau J. . 2000 Endocrinology 141: 922–931. · doi:10.1210/endo.141.3.7390 · Paper page
Cited by
GSK3 takes centre stage more than 20 years after its discovery
FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433
Decision making by p53: life, death and cancer
Oren, M. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401183 · Cited by 1,068
Wnt Signaling through Inhibition of β-Catenin Degradation in an Intact Axin1 Complex
Li, V. S. W., Ng, S. S., Boersema, P. J., Low, T. Y., Karthaus, W. R., Gerlach, J. P., Mohammed, S., Heck, A. J. R., Maurice, M. M., Mahmoudi, T., et al. (2012) · Cell · doi:10.1016/j.cell.2012.05.002 · Cited by 889
Phosphorylation of β-Catenin by AKT Promotes β-Catenin Transcriptional Activity
Fang, D., Hawke, D., Zheng, Y., Xia, Y., Meisenhelder, J., Nika, H., Mills, G. B., Kobayashi, R., Hunter, T., & Lu, Z. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611871200 · Cited by 870
The role of signaling pathways in the development and treatment of hepatocellular carcinoma
Whittaker, S., Marais, R., & Zhu, A. X. (2010) · Oncogene · doi:10.1038/onc.2010.236 · Cited by 825
Metadata
- Authors
- Desbois-Mouthon, C., Cadoret, A., Blivet-Van Eggelpoël, M.-J., Bertrand, F., Cherqui, G., Perret, C., & Capeau, J.
- Affiliations
- Inserm (FR)
- Venue
- Oncogene
- Published
- 2001-01-11
- Volume
- 20
- Issue
- 2
- Pages
- 252-259
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2069349104
- Cited by
- 321
- References
- 51
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 9 · 2023: 10 · 2022: 8 · 2021: 11 · 2020: 15 · 2019: 14 · 2018: 11 · 2017: 12 · 2016: 5 · 2015: 11 · 2014: 13 · 2013: 25 · 2012: 16
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- insulin, insulin-like growth factor I, β-catenin signaling, GSK-3β inhibition, Ras signaling, PI3K/Akt signaling, MEK1, hepatocarcinogenesis, hepatoma cells, signal transduction
- MeSH terms
- Cell Division, Cytoskeletal Proteins, DNA-Binding Proteins, Enzyme Activation, Enzyme Inhibitors, Flavonoids, Carcinoma, Hepatocellular, Humans, Insulin, Insulin-Like Growth Factor I, Mutation, Proto-Oncogene Proteins, Genes, ras, Transcription Factors, Transcription, Genetic, Tumor Cells, Cultured, Signal Transduction, Trans-Activators, Protein Serine-Threonine Kinases, Calcium-Calmodulin-Dependent Protein Kinases, Genes, Reporter, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinase Kinases, Glycogen Synthase Kinases, Glycogen Synthase Kinase 3, MAP Kinase Kinase 1, Proto-Oncogene Proteins c-akt, beta Catenin, Lymphoid Enhancer-Binding Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.